|Daily Range||$75.04 - $77.43|
|52-Week Range||$53.53 - $84.25|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,596,527|
|Current FY EPS||-$1.69|
BioMarin Pharmaceutical (BMRN) Description
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website: http://www.bmrn.com/
Can Alexion Pharmaceuticals retain its top orphan drug maker status, or will this one trick pony lose its audience?
Orphan drugmakers have been soaring over the past two years, and BioMarin is no exception. After such large gains, however, investors should consider if BioMarin can continue to head higher over the long-term.